Concepedia

Richard Rampulla

RR

Statistics

Publications

9

Citations

305

H-Index

9

Active since

2008

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (India)

Biocon (India)

Richard Rampulla is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

2008–2022

9

Publications

9

Discovery of 6-Fluoro-5-(<i>R</i>)-(3-(<i>S</i>)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)-2-methylphenyl)-2-(<i>S</i>)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1<i>H</i>-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton’s Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers

Scott H. Watterson, George V. De Lucca, Qing Shi et al. · Journal of Medicinal Chemistry · 2016 · 146 citations · Full text

, , +17

Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonists

Mark Salvati, Aaron Balog, Weifang Shan et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 34 citations · Full text

, , +12

Design, synthesis and biological evaluation of phenol-linked uncialamycin antibody-drug conjugates

Yam B. Poudel, Chetana Rao, Srikanth Kotapati et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 31 citations

, , +14

The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation

Alicia Regueiro‐Ren, Sing‐Yuen Sit, Yan Chen et al. · Journal of Medicinal Chemistry · 2022 · 27 citations · Full text

, , +17

Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer

Aaron Balog, Richard Rampulla, Greg S. Martin et al. · ACS Medicinal Chemistry Letters · 2015 · 20 citations · Full text

, , +17

1–5 of 9